Together, these mechanisms suggest that COL3A1, PLAU, and SPP1 not only serve as promising biomarkers for early-stage esophageal cancer but also contribute to the pathophysiology of the disease by facilitating key processes such as migration, invasion, and proliferation. This evidence concerns the gene PLAU and esophageal cancer.